Literature DB >> 3896576

A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications.

T Obayashi, H Tamura, S Tanaka, M Ohki, S Takahashi, M Arai, M Masuda, T Kawai.   

Abstract

A conventional limulus test is not specific to endotoxin because of the presence in amebocyte lysate of a (1----3)-beta-D-glucan-sensitive factor. By fractionating coagulation enzymes in the lysate and recombining only those factors involved in endotoxin-induced coagulation, we have developed a new test specific to endotoxin. The recombined enzymes reacted only with endotoxin, and not with fungal polysaccharides. Conventional amebocyte lysate, on the other hand, reacted with both of them. A good linearity was obtained with this method between endotoxin concentration and absorbance with a sensitivity of 1 pg/ml of Escherichia coli 0111:B4 endotoxin. The regression lines for different types of endotoxins were parallel to one another. For the correct diagnosis of endotoxemia, this new test has a definite advantage over the one using whole amebocyte lysate.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3896576     DOI: 10.1016/0009-8981(85)90273-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  44 in total

1.  Monocytic cell activation by Nonendotoxic glycoprotein from Prevotella intermedia ATCC 25611 is mediated by toll-like receptor 2.

Authors:  S Sugawara; S Yang; K Iki; J Hatakeyama; R Tamai; O Takeuchi; S Akashi; T Espevik; S Akira; H Takada
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Inhibition by 16,16-dimethyl prostaglandin E2 of tumor necrosis factor-alpha and interleukin-1beta production and messenger RNA expression in human monocytes stimulated by Helicobacter pylori.

Authors:  O Takaishi; T Arakawa; Y Fujiwara; T Fukuda; K Otani; K Yamasaki; K Higuchi; T Kuroki
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

3.  Significance of urinary endotoxin concentration in patients with urinary tract infection.

Authors:  T Matsumoto; M Tanaka; N Ogata; Y Mizunoe; K Takahashi; J Kumazawa
Journal:  Urol Res       Date:  1991

4.  Change in plasma endotoxin titres and endotoxin neutralizing activity in the perioperative period.

Authors:  T Imai; T Shiga; N Saruki; K Nishikawa; T Fujita; Y Morishita
Journal:  Can J Anaesth       Date:  1996-08       Impact factor: 5.063

Review 5.  Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.

Authors:  Hiroshi Fukui
Journal:  World J Hepatol       Date:  2015-03-27

6.  The Role of Biomarkers for Diagnosis of and Therapeutic Decisions Related to Invasive Aspergillosis in Children.

Authors:  Brian T Fisher
Journal:  Curr Fungal Infect Rep       Date:  2013-03-01

7.  Immunobiological activities of a 55-kilodalton cell surface protein of Prevotella intermedia ATCC 25611.

Authors:  K Matsushita; S Nagaoka; R Arakaki; Y Kawabata; K Iki; M Kawagoe; H Takada
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  Molecular and structural requirements of a lipoteichoic acid from Enterococcus hirae ATCC 9790 for cytokine-inducing, antitumor, and antigenic activities.

Authors:  H Takada; Y Kawabata; R Arakaki; S Kusumoto; K Fukase; Y Suda; T Yoshimura; S Kokeguchi; K Kato; T Komuro
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

9.  Requirement of a properly acylated beta(1-6)-D-glucosamine disaccharide bisphosphate structure for efficient manifestation of full endotoxic and associated bioactivities of lipid A.

Authors:  I Takahashi; S Kotani; H Takada; M Tsujimoto; T Ogawa; T Shiba; S Kusumoto; M Yamamoto; A Hasegawa; M Kiso
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

10.  Immunobiological activities of synthetic lipid A analogs with low endotoxicity.

Authors:  S Kotani; H Takada; I Takahashi; T Ogawa; M Tsujimoto; H Shimauchi; T Ikeda; H Okamura; T Tamura; K Harada
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.